Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm
The Research of Autologous Adipose Mesenchymal Stem Cell Transplantation for Treatment of Facial 、Auditory Nerve Dysfunction of Patients With Hemifacial Spasm After Microvascular Decompression.
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
This EARLY_PHASE1 trial investigates Injury of Facial Nerve, Unspecified Side, Initial Encounter and is currently ongoing. Xinhua Hospital, Shanghai Jiao Tong University School of Medicine leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Sep 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting Phase 0
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.